20 related articles for article (PubMed ID: 30916533)
1. Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study.
Zhou Y; Wang Y; Zhang Z; Yin X; Liu J; Zheng W
J Clin Endocrinol Metab; 2023 Nov; 108(12):3330-3337. PubMed ID: 37267432
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer.
Gao H; Huang J; Dai Q; Su J
Arch Endocrinol Metab; 2023 Mar; 67(2):197-205. PubMed ID: 36651706
[TBL] [Abstract][Full Text] [Related]
3. Observation Variation in Ultrasonography Assessment of Thyroid Nodules.
Sharifi Y; Shafiei S; Tabesh H; Aminzadeh B; Layegh P; Mahmoodzadeh A; Zakavi SR; Eslami S
Asia Ocean J Nucl Med Biol; 2022; 10(1):28-35. PubMed ID: 35083347
[TBL] [Abstract][Full Text] [Related]
4. Longer Time to Reach Excellent Response to Treatment in Familial Versus Sporadic Non-medullary Thyroid Cancer (NMTC): A Matched Case-Control Study.
Shafiei S; Sadrolodabaei M; Aghaei A; Ayati N; Zare Namdar S; Hemati D; Zakavi SR
Int J Endocrinol Metab; 2021 Apr; 19(2):e108781. PubMed ID: 34149846
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
[TBL] [Abstract][Full Text] [Related]
6. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer.
Bandeira L; Padovani RDP; Ticly AL; Cury AN; Scalissi NM; Marone MMS; Ferraz C
Arch Endocrinol Metab; 2017 Dec; 61(6):590-599. PubMed ID: 29412384
[TBL] [Abstract][Full Text] [Related]
8. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic
Trevizam PG; Tagliarini JV; Castilho EC; de Alencar Marques M; Kiy Y; Mazeto GMFS
Endocr Res; 2017 Feb; 42(1):42-48. PubMed ID: 27144920
[TBL] [Abstract][Full Text] [Related]
10. Radioactive iodine therapy: multiple faces of the same polyhedron.
do Prado Padovani R; Chablani SV; Tuttle RM
Arch Endocrinol Metab; 2022 May; 66(3):393-406. PubMed ID: 35551676
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC.
Zakavi SR; Ayati N; Zare S; Ayati A; Sadri K; Fekri N; Abbasi B; Shafiei S
Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):64-71. PubMed ID: 30916533
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
